Since global CVD is predicted to rise in line with an ongoing obesity epidemic, then understanding the molecular mechanisms by which Brn-3b drives diverse effects in different tissues can provide insights into how the loss of Brn-3b contributes to pathological changes in metabolic and cardiovascular diseases, but could also provide different approaches for earlier diagnosis and effective treatment. This evidence concerns the gene POU4F2 and Obesity.